An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.

Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.

A diminutive protein prompts a closer look at DNA dark matter.

For patients with lung cancer, biomarker testing may be an option.